Issue 5/2014
Content (12 Articles)
Ethical Objections Against Including Life-Extension Costs in Cost-Effectiveness Analysis: A Consistent Approach
Afschin Gandjour, Dirk Müller
EXOGEN Ultrasound Bone Healing System for Long Bone Fractures with Non-Union or Delayed Healing: A NICE Medical Technology Guidance
Ailish Higgins, Matthew Glover, Yaling Yang, Susan Bayliss, Catherine Meads, Joanne Lord
E-Vita Open Plus for Treating Complex Aneurysms and Dissections of the Thoracic Aorta: A NICE Medical Technology Guidance
Muralikrishnan Radhakrishnan, Janet Peacock, Tiago Rua, Rachel E. Clough, Mercy Ofuya, Yanzhong Wang, Elizabeth Morris, Cornelius Lewis, Stephen Keevil
What is the Quality of Economic Evaluations of Non-Drug Therapies? A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer
M. Barbieri, H. L. A. Weatherly, R. Ara, H. Basarir, M. Sculpher, R. Adams, H. Ahmed, C. Coles, T. Guerrero-Urbano, C. Nutting, M. Powell
Examining the Influence of Antenatal Care Visits and Skilled Delivery on Neonatal Deaths in Ghana
Monica P. Lambon-Quayefio, Nkechi S. Owoo
Diagnostic Needle Arthroscopy and the Economics of Improved Diagnostic Accuracy: A Cost Analysis
Jeffrey D. Voigt, Michael Mosier, Bryan Huber
The Impact on Health Outcomes and Healthcare Utilisation of Switching to Generic Medicines Consequent to Reference Pricing: The Case of Lamotrigine in New Zealand
Charon Lessing, Toni Ashton, Peter Davis
Comparing Hospital-Based Resource Utilization and Costs for Prostate Cancer Patients With and Without Bone Metastases
Brian Seal, Sean D. Sullivan, Scott D. Ramsey, Carl V. Asche, Ken Shermock, Syam Sarma, Erin A. Zagadailov, Eileen Farrelly, Michael Eaddy
Comment on: “Insulin Glargine in a Brazilian State: Should the Government Disinvest?”
Domingos A. Malerbi
Authors’ Reply to Dr. Malerbi: “Insulin Glargine in a Brazilian State: Should the Government Disinvest?”
Ana Luísa Caires de Souza, Francisco de Assis Acurcio, Augusto Afonso Guerra Júnior, Renata Cristina Rezende Macedo do Nascimento, Brian Godman, Leonardo Maurício Diniz
Comment on: “Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers”
Alessandro Curto, Livio Garattini
Authors’ Reply to Curto and Garattini: “Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers”
Josh J. Carlson, Katie Gries, Kai Yeung, Sean D. Sullivan, Louis P. Garrison